-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QrbTqO/bQtkWHIGSkmtU8p4W6EnT8Hpu5VfDkxVViLzsmKaHdJW+9a0K7ave8UTU cfMolB4V8o2zbNWfKPg7tQ== 0000950144-97-002643.txt : 19970321 0000950144-97-002643.hdr.sgml : 19970321 ACCESSION NUMBER: 0000950144-97-002643 CONFORMED SUBMISSION TYPE: SC 13G CONFIRMING COPY: PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970320 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOFIELD CORP \DE\ CENTRAL INDEX KEY: 0001007018 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 133703450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-45809 FILM NUMBER: 00000000 BUSINESS ADDRESS: STREET 1: 1225 NORTHMEADOW PARKWAY STREET 2: STE 120 CITY: ROSWELL STATE: GA ZIP: 30076 BUSINESS PHONE: 7707408180 MAIL ADDRESS: STREET 1: 1225 NORTHMEADOW PKWY STREET 2: SUITE 120 CITY: ROSWELL STATE: GA ZIP: 30076 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GORDON C LEONARD CENTRAL INDEX KEY: 0000931575 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 360 LEXINGTON AVENUE STREET 2: C/O IMMUNOTHERAPY INC CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125994455 MAIL ADDRESS: STREET 1: 360 LEXINGTON AVENUE STREET 2: C/O IMMUNOTHERAPY INC CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G 1 BIOFIELD CORPORATION 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------- SCHEDULE 13G Under the Securities Exchange Act of 1934 Biofield Corp. ----------------------------------------------------- (Name of Issuer) Common Stock, par value $.001 per share ---------------------------------------------------------------- (Title of Class of Securities) 090591 10 8 ----------------------------------------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with the statement [X] (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following pages) (Page 1 of 5 Pages) 2 CUSIP NO. 090591 10 8 13G Page 2 of 5 Pages 1 NAME OF REPORTING PERSONS/S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS C. Leonard Gordon [ ] 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America Number of 5 SOLE VOTING POWER Shares Beneficially 980,232 (joint with wife) Owned by 6 SHARED VOTING POWER Each 0 Reporting Person with 7 SOLE DISPOSITIVE POWER 980,232 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 980,232 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 15.24% 12 TYPE OF REPORTING PERSON IN
3 CUSIP NO. 090591 10 8 13G Page 3 of 5 Pages ITEM 1(A). NAME OF ISSUER: -------------- Biofield Corp. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: ----------------------------------------------- 1225 Northmeadow Parkway, Suite 120, Roswell, Georgia 30076 ITEM 2(A). NAME OF PERSON FILING: --------------------- C. Leonard Gordon ITEM 2(B). ADDRESS OF PRINCIPAL OFFICE, OR IF NONE, RESIDENCE: -------------------------------------------------- c/o Immunotherapy Inc., 360 Lexington Ave., New York, New York 10017 ITEM 2(C). CITIZENSHIP: ----------- United States of America. ITEM 2(D). TITLE OF CLASS OF SECURITIES: ---------------------------- Common Stock, par value $.001 per share. ITEM 2(E). CUSIP NUMBER: ------------ 090591 10 8 ITEM 3. BECAUSE THIS STATEMENT IS NOT FILED PURSUANT TO RULES 13D-1(B) OR 13D-2(B), THIS ITEM IS: ----------------------------------------- Not Applicable.
4 CUSIP NO. 090591 10 8 13G Page 4 of 5 Pages ITEM 4. OWNERSHIP: The following information is as of December 31, 1996: (a) Amount Beneficially Owned: 980,232 (b) Percent of Class: 15.24% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 980,232 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 980,232 (iv) shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class securities, check the following [ ]. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not Applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not Applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP: Not Applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not Applicable. ITEM 10. CERTIFICATION: Not Applicable.
5 CUSIP NO. 090591 10 8 13G Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 6, 1997 \s\ C. Leonard Gordon -------------------------------- C. LEONARD GORDON -----END PRIVACY-ENHANCED MESSAGE-----